Finance

Lists
Why is DTC up 11.76%?
Dive Deeper
DTC:CNSX
Defence Therapeutics Inc
CA$0.38
+11.76%
(+0.040) 1D
Oct 19, 4:00:00ā€ÆPM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for DTC...
Open
CA$0.38
High
CA$0.38
Low
CA$0.38
Mkt. cap
21.79M
Avg. vol.
37.27K
Volume
14.69K
52-wk high
CA$0.93
52-wk low
CA$0.34
EPS
-CA$0.11
Open
CA$0.38
High
CA$0.38
Low
CA$0.38
Mkt. cap
21.79M
Avg. vol.
37.27K
Volume
14.69K
52-wk high
CA$0.93
52-wk low
CA$0.34
EPS
-CA$0.11
News stories
From web sources and news partners
About Defence Therapeutics Inc
CEO-
Employees-
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitedefencetherapeutics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
335.23K
115.60K
316.51K
729.19K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
922.56K
353.71K
964.46K
401.52K
Operating expense
1.42M
599.46K
1.37M
1.16M
Total operating expenses
1.42M
599.46K
1.37M
1.16M
Operating income
-1.42M
-599.46K
-1.37M
-1.16M
Other non operating income
315.48K
-75.71K
-36.17K
-1.75M
EBT including unusual items
-1.16M
-703.00K
-1.52M
-2.96M
EBT excluding unusual items
-1.08M
-703.00K
-1.52M
-2.96M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.16M
-703.00K
-1.52M
-2.96M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
631.00
-
Interest expense
-21.68K
-11.92K
-111.06K
-76.49K
Net interest expenses
-21.68K
-11.92K
-110.43K
-76.49K
Depreciation and amortization charges
19.21K
16.24K
9.28K
9.42K
EBITDA
-1.41M
-589.88K
-1.36M
-1.15M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps